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Abstract: Oxidative stress caused by an imbalanced metabolism and an excess of reactive 
oxygen species (ROS) lead to a range of health disorders in humans. Our endogenous 
antioxidant defense mechanisms and our dietary intake of antioxidants potentially regulate 
our oxidative homeostasis. Numerous synthetic antioxidants can effectively improve defense 
mechanisms, but because of their adverse toxic effects under certain conditions, preference is 
given to natural compounds. Consequently, the requirements for natural, alternative sources 
of antioxidant foods identified in edible mushrooms, as well as the mechanistic action 
involved in their antioxidant properties, have increased rapidly. Chemical composition and 
antioxidant potential of mushrooms have been intensively studied. Edible mushrooms might 
be used directly in enhancement of antioxidant defenses through dietary supplementation to 
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reduce the level of oxidative stress. Wild or cultivated, they have been related to significant 
antioxidant properties due to their bioactive compounds, such as polyphenols, polysaccharides, 
vitamins, carotenoids and minerals. Antioxidant and health benefits, observed in edible 
mushrooms, seem an additional reason for their traditional use as a popular delicacy food. 
This review discusses the consumption of edible mushrooms as a powerful instrument in 
maintaining health, longevity and life quality. 
Keywords: antioxidants; edible mushrooms; health; life quality; longevity; oxidative stress; 
reactive oxygen species 
 
1. Introduction 
Inadequate nutrition due to modern lifestyle and the increase of average longevity are the two key reasons 
for the growing incidence of disease all over the world. Oxidative stress caused by an imbalanced metabolism 
and an excess of reactive oxygen species (ROS) end into a range of disorders i.e., metabolic disease, heart 
disease, severe neural disorders such as Alzheimer’s and Parkinson’s, premature aging and some cancers. 
ROS are not only generated internally, in the organism, but also through various external sources like 
ultraviolet light, ionizing radiation, chemotherapeutics, inflammatory cytokines, and environmental toxins. 
Inhaling toxic chemicals from the environment has become unavoidable in modern civilization. 
Apart of the endogenous antioxidant defense mechanisms of an organism, its dietary intake is another 
very important source of antioxidants and may contribute to oxidative homeostasis. Antioxidant supplements 
or antioxidant-containing foods may be used to help the organism to reduce oxidative damage as well  
to protect food quality by preventing oxidative deterioration. Just as in food production and packing, 
antioxidants are extensively used in health care, anti-aging and cosmetics. The growing preference for 
healthy food, cosmetics, and health and wellness products is influencing the growth of the antioxidants 
market. In addition, increasing demand for nutritional products and cosmetics obtained from natural 
sources is also driving the natural antioxidants market [1]. Population growth and the increasing healthcare 
spending levels have led to a consistent increase in the demand for antioxidant products. The global 
market for antioxidants is growing fast and is expected to more than double from $103.6 million in 2011 
to reach $246.1 million in 2018 [2,3]. 
The antioxidants market by product type is segmented into natural antioxidants and synthetic 
antioxidants. Natural antioxidants are categorized into plant and fungal extracts, spices (rosemary, thyme, 
marjoram, oregano, sage, basil, pepper, clove, cinnamon, and nutmeg), flavonoids, ubiquinol (fully reduced 
form of coenzyme Q10), glutathione, zink (Zn), selenium (Se), vitamin A (including carotenoids), vitamin C 
and vitamin E (including tocopherols and tocotrienols) [4]. 
Synthetic phenolic antioxidants include butylated hydroxyanisole (BHA), butylated hydroxytoluene 
(BHT) and others e.g., propyl gallate, tert-butylhydroquinone (TBHQ), ethoxyquin (EQ), that all effectively 
inhibit oxidation [5]. However, some synthetic antioxidants may cause adverse toxic effects under certain 
conditions [6,7]. BHA, which is very often used as an additive in food industry, can have negative effects on 
the regulation of the activity of mitogen-activated protein kinase (MAPK) depending on the dosage [7,8]. 
Several synthetic antioxidants are authorized for use as feed additives in the European Union [9]. 
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In recent years, the restriction on the use of synthetic antioxidants, such as BHA and BHT, has caused 
a rapidly increased interest towards natural antioxidant substances [6,7]. Requirements for natural 
alternative sources of antioxidant foods and ingredients derive primarily from consumers. 
In recent years edible mushrooms have attracted attention as a commercial source of antioxidants [6,7,10]. 
They might be used directly in enhancement of antioxidant defenses through dietary supplementation to 
reduce the level of oxidative stress. There is a wealth of evidence to support the effectiveness of such a 
strategy in vitro. 
Edible mushrooms include many fungal species that are either harvested wild or cultivated. Cultivated 
mushrooms as well as the more common wild mushrooms are often available in markets; porcini  
(Boletus edulis) or other ectomycorhyzal mushrooms may be collected on a smaller scale by private 
gatherers [11,12]. 
The true nutritive value of mushrooms has rapidly become known and recognized not only by 
mushroom researchers and farmers but also by the general consumers [13]. In addition to their good flavor, 
mushrooms possess favorable chemical composition with high amounts of functional proteins, low total 
fat level, and the high proportion of polyunsaturated fatty acids (PUFA), making them well suited for 
low calorie diets. Edible mushrooms provide a nutritionally significant content of vitamins (B1, B2, B12, 
C, D, and E) [14–16]. Moreover, mushrooms have a low glycemic index, and high mannitol, which is 
especially beneficial for diabetics. Mushrooms have very low sodium (Na) concentration, which is beneficial 
for hypertensive patients and a high content of potassium (K) and phosphorus (P), which is an important 
orthomolecular aspect [13]. In Asia mushrooms are used as important source of home remedies against 
various diseases elicited by oxidative stress [10]. 
There is no easy distinction between edible and medicinal mushrooms because many of the common 
edible species have therapeutic properties [12,17]. Besides antioxidant properties, mushrooms have received 
considerable attention for their biological activities, such as antitumor, antiviral, anticomplementary, 
anticoagulant, antidiabetic, hypolipidemic, hepatoprotective, immunostimulant and immunological 
activities, which made them suited for use in food, cosmetics, biomedicine, agriculture, environmental 
protection and wastewater management [7,18,19]. 
To date, a numerous edible wild mushroom species, growing in various ecological conditions, are 
known [20]. The common mushroom species produced in suitable ecological conditions are: Agaricus spp., 
Lentinula edodes (shiitake), Pleurotus spp. (oyster), Volvariella volvacea (straw), Hericium erinaceus 
(Lion’s head or pom pom), Auricularia auricula-judae (ear), Grifola frondosa (maitake), Ganoderma 
lucidum (lingzhi), Flammulina velutipes, Tremella fuciformis, Pholiota nameko, Lepista nuda (blewit) 
and Coprinus comatus (shaggy mane). Those of highest economic value are usually produced under 
artificial conditions, i.e., on a well defined substrate and under full climatization. These are mostly 
Agaricus bisporus (button mushroom), Lentinula edodes, Pleurotus spp., and Flammulina velutipes [20]. 
Mushrooms production is continuously increasing, with China being the biggest producer around the 
world [12] (Figure 1). 
The Netherlands can be distinguished as the country at the forefront of European mushroom cultivation. 
Over the past 40 years a unique industry was established, resolute research carried on and exemplary 
education in mushroom growing was organized. The most important European country for the import of 
fresh and canned mushrooms is Germany. Mushroom production in Poland has increased intensely over 
the last 20 years and is now the largest in Europe [21]. 
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In this work we review the antioxidant compounds identified in edible mushrooms, as well as the 
mechanistic aspects behind their antioxidant properties. The present review supplies a critical overview 
and is meant to promote further research and development of mushrooms. 
 
Figure 1. Map of edible mushroom species that are commonly grown commercially all over 
the world. 
2. ROS and Antioxidants in Cell Metabolism and Their Consequences in Human Cells  
and Health 
2.1. Introduction to ROS 
In the mid-1950s, Harman published a “Free-Radical Theory of Ageing”, speculating that endogenous 
oxygen radicals were generated in cells and resulted in a pattern of cumulative damage. When the supply 
of antioxidants was insufficient, Harman speculated, the resulting cell damage triggers a cascade of events 
that leads to disease development and death [14,22]. 
Since that hypothesis, our knowledge on involvement of free radicals and antioxidants in living processes 
has grown enormously. The field of free radicals or more common reactive species (RS) research in 
biological systems has become one of the most dynamic. 
Homeostasis is strongly influenced by many RS [23], such as ROS, reactive nitrogen (RNS), reactive 
carbon (RCS) and reactive sulfur species (RSS) (Figure 2). There are also many other RS consisting of 
halogens and related compounds [23]. 
ROS represent the most important class of reactive species generated in living systems [6,23].  
In eukaryotic cells over 90% of ROS are produced by mitochondria via escape of electrons from the 
mitochondrial electron transport system (ETS), mainly from coenzyme Q to molecular oxygen (O2), resulting 
in the generation of superoxide anion radical (•O2−), named “primary” ROS. Further, •O2− spontaneously 
or enzymatically, can be dismutated into hydrogen peroxide (H2O2) and O2. H2O2 is not a free radical, but 
is chemically more active than O2 due to which it is included in the ROS group. It possesses the ability to 
form the more damaging •OH, through a combination of the Fenton and Haber-Weiss reactions [23,24]. 
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Finally, ·OH interacts with one more electron and proton resulting in the formation of a water molecule 
(H2O). In biological systems, this reaction is mainly realized through abstraction of a hydrogen atom which 
originates from different compounds such as proteins and lipids, resulting frequently in initiation of radical 
chain processes. Besides of mitochondrial ETS, minor ROS are generated by ETS located in/at endoplasmic 
reticulum (ER), plasmatic, and nuclear membranes [23]. 
 
Figure 2. Classification of reactive species (RS) in living systems. Depending on the active 
center (ac) they are classified as: reactive oxygen species (ROS), ac-oxygen; reactive nitrogen 
species (RNS), ac-nitrogen; reactive carbon species (RCS), ac-carbon and reactive sulfur 
species (RSS), ac-sulfur. 
Diverse oxidases are also rather powerful ROS producers [23,25] (Figure 3). The physiological role of 
xanthine oxidase (XO) in total ROS balance, has received substantial attention. It is believed that under 
hypoxic conditions this enzyme may be the main ROS producer [26]. Additionally, autoxidation in the 
organism of different small molecules, such as adrenalin and norepinephrine, is also coupled with ROS 
production [27]. Even growth factors generate high levels of ROS that can perturb the normal redox 
balance and shift cells into a state of oxidative stress [14]. 
 
Figure 3. Endogenous and exogenous factors inducing ROS generation. 
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There are multiple external factors that induce ROS generation (Figure 3). Environmental pollution, 
radiation, cigarette smoking, certain foods, and drugs are the major exogenous sources of ROS. Many 
xenobiotics, especially different homo- and heterocyclic compounds, are clearly related as ROS generators 
in autooxidation reactions [6,23]. Inadequate nutrition, due to modern lifestyle, may also indirectly result 
in oxidative stress which impairs the cellular defense mechanisms. 
2.2. Positive Effects of ROS in Homeostasis 
ROS are a double-edge sword [28]. Despite their harmful effects the beneficial physiological cellular use 
of ROS is now being demonstrated in different fields [29]. Low physiological levels of ROS function as 
secondary messengers in intracellular signaling and are required for normal cell functions (Table 1). It is well 
documented that low levels of ROS can modulate cell proliferation, apoptosis, and gene expression 
through activation of transcription factors, like Nuclear Factor Kappa B (NF-κB) and hypoxia-inducible-
factor-1α (HIF) [28,30–34]. 
Table 1. ROS signaling is integrated into many cellular pathways [28,29]. 
No. Cellular Pathways 
1 
proliferation and survival pathways through mitogen-activated protein kinase (MAPK), 
phosphoinositide 3-kinase (PI3), phosphatase and tensin homolog (PTEN),  
and protein tyrosine phosphatases 
2 
ROS homeostasis and antioxidant gene regulation through redox effector factor-1 (Ref-1),  
NF-E2-related factor (Nrf-2), thioredoxin 
3 
Aging through p66Shc, a member of the Src homologous-collagen homologue (ShcA)  
adaptor protein family 
4 
DNA damage response through ataxia-telangiectasia mutated kinase (ATM); this may lead to 
inhibition of the mammalian target of the rapamycin complex 1 (mTORC1) resulting  
in suppression of protein synthesis and activation of autophagy 
5 Iron homeostasis through iron-regulatory proteins (IRP) and iron-responsive elements (IRE) 
A moderate increase of ROS may protect from infections caused by a broad range of  
microorganisms [35]. The production of •O2− and H2O2 by activated phagocytes is the classic example of the 
deliberate metabolic generation of ROS for useful purposes [28,36]. Moderate amounts of mitochondrial 
•O2− and H2O2 have important roles in a range of cellular signaling processes and can activate signaling 
pathways that promote cell survival and disease resistance due to hormesis [28,37]. Generation of •O2−, 
HOCl, and H2O2 by phagocytes is important for defense against various bacterial and fungal strains [38]. 
For example individuals with chronic granulomatous disease who have deficiencies in generating ROS,  
are highly susceptible to infection by a broad range of microbes including Salmonella enterica, 
Staphylococcus aureus, Serratia marcescens, and Aspergillus spp. [39,40]. ·O2− is produced also by 
several cell types other than phagocytes, including lymphocytes and fibroblasts [28]. 
Detoxification reactions, ensured by the cytochrome P450 family, are dependent on the integrity of the 
microsomal ROS generating system. Nicotinamide adenosine dinucleotide phosphate (NADPH) supplies 
electrons, required for the reduction of O2 and the formation of ROS by microsomal monooxygenases, 
which have cytochrome P450 as a central link. They oxidize hydrophobic toxic substances, steroids and 
drugs, transforming them into hydrophilic compounds, which are removed from the body [41,42]. 
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Further, a moderate increase of ROS is involved in apoptosis which eliminates cancerous and other 
life-threatening cells [35]. Apoptosis sometimes called “a guardian angel” or “cell policeman” [42], is 
carried out by a multistage chain of reactions, arises in cancer cells, in which ROS act as triggers and 
essential mediators [42]. 
Mitochondria play a critical role in apoptosis [43]. Apoptotic signals promote accumulation of the p53 
protein that triggers the release of ROS, cytochrome C and a few other regulators from mitochondria [42]. 
ROS can act as signaling intermediates for cytokines, including interleukin 1 (IL-1) and the tumor necrosis 
factor (TNF) family [28,44–46]. Members of the TNF cytokine family, such as TNFα and Fas ligand (FasL), 
play important roles in inflammation and immunity [47,48]. Although TNF-related apoptosis-inducing 
ligand (TRAIL) is a member of this family, this molecule can induce (most, but not all) cancer cell death 
by its binding to the death receptors (DR), while causing almost no cytotoxicity to normal cells [47,49,50]. 
Normal cells are reported to show TRAIL-resistance with their preferential expression of decoy receptors 
(DcRs), which inhibit apoptotic signaling [51]. 
TRAIL-induced activation is a cascade of proteolytic enzymes, called caspases, which digest a number 
of cancer cell proteins and promote a caspase-activated deoxyribonuclease. Cleavage of the critical 
proteins and deoxyribonucleic acid (DNA) results in apoptotic cell death [42]. Also some reports suggest 
that TRAIL can induce necroptosis in cancer cells via ROS signaling [47,52–54]. 
In modern medicine generation of ROS by prooxidant compounds increasingly attracts attention as a 
therapeutic strategy for cancer [35]. For example, the compound 4-benzyl-2-methyl-1,2,4-thia-diazolidine-
3,5-dione (TDZD-8) can induce depletion of thiols and rapid accumulation of ROS and selectively  
kill leukemic cells that express stem-cell markers, with minimal toxicity to normal hematopoietic stem  
cells [55]. Because tumor stem cells are thought to be the subpopulation of cells that are highly resistant 
to chemotherapy and play a critical role in disease relapse after treatment, the potency of the prooxidative 
compound in removing these cells underscores a key role of the redox system in regulating survival of 
stem cells and highlights the promising therapeutic potential of using a redox-based strategy in cancer 
treatment [35]. 
A transient increase of levels of oxidative stress by physical exercise reflects a potentially health 
promoting process at least in regards to prevention of insulin resistance and type 2 diabetes mellitus [56]. 
Physical training has been shown to improve glucose metabolism [57] by inducing molecular regulators 
of insulin sensitivity and endogenous antioxidant defense [56]. Exercise, as well as weight loss, has been 
linked to activation of mitochondrial metabolism, and reduced mitochondrial metabolism has been 
functionally connected with type 2 diabetes [58]. Muscle tissue is also known to generate ROS, especially 
during contraction and physical exercise [59]. 
2.3. Elimination of ROS in Living Systems 
Living organisms possess a multilevel and complicated antioxidant system operating either to eliminate 
ROS, or to minimize their negative effects. Major ROS defense mechanisms include enzymatic and 
nonenzymatic systems (Figure 4). The ROS which are not neutralized can target biological molecules such 
as DNA, lipids and proteins, which can result in cell death or dysfunction and accelerated ageing and 
age-related diseases [14,23]. 
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Figure 4. Major ROS defense mechanisms in the organism. 
There are many different endogenous enzymatic antioxidant defense systems in the organism, either 
in intracellular or extracellular medium. They primarily include superoxide dismutase (SOD), catalase 
(CAT), glutathione peroxidases (GPx), and glutathione redutase (Gred) (Figure 4). Red blood cells are 
particularly sensitive to oxidative environments throughout the body and, as a consequence of their iron 
(Fe) content, are capable of producing their own ROS. However, the presence of antioxidant enzymes such 
as SOD and CAT, and methemoglobin reductase which catalyzes the reduction of methemoglobin to 
hemoglobin, minimized these processes [24,60]. The red blood cells and hepatocytes possess the highest 
level of CAT activity in the human body [60,61]. 
Nonenzymatic ROS defense mechanisms include low molecular mass antioxidants such as vitamins 
C and E, carotenoids including vitamin A, polyphenols, uric acid, (Figure 4) and large molecules i.e., 
albumin, ceruloplasmin, transferrin, ferritin [62]. In addition, Zn, copper (Cu), manganese (Mn), Fe, and Se 
are key components of enzymes with antioxidant functions and are designated as antioxidant micronutrients. 
Most of them are available to the human organism as food or supplement components [23,25,62–64]. 
Very important nonenzymatic antioxidants are glutathione (GSH), synthesized by most living organisms, 
and melatonin. As melatonin can directly cross the mitochondrial membranes, it plays a very significant 
role in the protecting mitochondria from oxidative damage. Probably due to antioxidant activity melatonin 
can improve glucose metabolism via correction of insulin production protecting pancreatic β-cells against 
ROS induced damage [65]. Other hormones. i.e., estrogen and angiotensin, also express antioxidant 
activity [63,66,67]. 
Alterations of the balance between ROS production and the capacity to rapidly detoxify reactive 
intermediates lead to oxidative stress. It has been implicated in a wide variety of states, processes and disease, 
e.g., aging, ischemia-reperfusion (I/R) injury, muscle damage, hypertension, atherosclerosis, diabetes, 
renal diseases, liver diseases, neurological diseases including Parkinson’s disease, Alzheimer’s disease 
and other forms of dementia, as well as diverse cancers. Oxidative stress also contributes to various 
gastrointestinal (GI) diseases including gastroduodenal ulcers, inflammatory bowel disease, and GI 
malignancies such as gastric and colorectal cancer [23,25,68]. 
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2.4. Regulation of Antioxidant Systems 
Under oxidative stress, an organism develops responses to prevent or neutralize negative ROS effects. 
These responses are mainly based on up-regulation of antioxidant and related enzymes. Mechanisms 
include ROS sensing, transduction of signals through specific pathways and up-regulation of target genes 
to enhance level of their products [23]. 
The human organism possesses a complicated system of adaptive responses to ROS exposure. Usually, 
it has several components (Figure 5). Under low intensity oxidative stress, the Kelch-like ECH-associated 
protein 1/NF-E2-related factor 2 (Keap1/Nrf2) system up-regulates genes encoding antioxidant enzymes. 
It is known to be activated by minute amounts of ROS. Intermediate intensity oxidative stress up-regulates 
antioxidant enzymes and induces inflammation proteins and heat shock proteins via NF-κB, activator 
protein-1 (AP1), MAPKs and heat shock factor (HSF). Under high intensity oxidative stress perturbations 
of mitochondrial permeability transition pore, activation of apoptosis cascade, destruction of electron 
transporters take place, which may culminate in apoptosis and/or necrosis [23,69]. 
 
Figure 5. Human and animal organism system of adaptive response to ROS exposure. 
Up-regulation of antioxidant systems increases their capability to eliminate ROS creating in this way 
autoregulated negative feedback control loop. 
3. Antioxidant Compounds in Mushrooms 
A whole range of edible mushrooms were reported to possess antioxidant activity (Table 2). It is 
generally accepted that extracts of fungi contain many components, each of which has its own specific 
biological effects [70,71]. Antioxidant compounds found in fruit bodies, mycelium and broth confirmed to 
be phenolics, flavonoids, glycosides, polysaccharides, tocopherols, ergothioneine, carotenoids, and ascorbic 
acid [16,17,72–148]. 
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Table 2. Some studies of antioxidative properties of wild and cultivated mushrooms.  
Mushroom Species References 
Agaricus bisporus, Agaricus brasiliensis (=Agaricus blazei ss. Heinem.), Agrocybe aegerita, Auricularia auricular, Auricularia cornea, 
Auricularia polytricha, Auricularia mesenterica, Auricularia fuscosuccinea, Agrocybe cylindracea, Amanita rubescens,  
Agaricus arvensis, Armillariella mellea, Agaricus silvicola, Agaricus silvaticus, Agaricus romagnesii, Antrodia camphorate 
[75,77,81–83,90,91,93,97,103,104, 
112,115,117,121,123,125,129–133, 
135,139,140,142,144] 
Boletus edulis, Boletus badius [91,123,144] 
Cantharellus lutescens, Cantharellus clavatus, Cantharellus cibarius, Cordyceps sinensis, Calvatia gigantea, Cerrena unicolor,  
Coprinus comatus 
[16,91,93,97,104,115,134,140,142, 
144,147] 
Dictophora indusiata [114] 
Flammulina velutipes (white), Flammulina velutipes (yellow) [95,103,105,136–138] 
Inonotus obliquus [78–80] 
Ganoderma lucidum, Ganoderma tsugae, Grifola frondosa, Ganoderma applanatum, Geastrum arenarius, Geastrum saccatum, 
Ganoderma atrum 
[74–76,86–89,91,93,94,96,98,99,107, 
109–111,114,118,119,127,142,145,146] 
Hericium erinaceus, Hericium coralloides, Hydnum repandum, Hygrophorus agathosmus, Hypsizigus marmoreus,  
Hypholoma fasciculare, Helvella crispa 
[91,97,103,113–115,123,140,147] 
Lepista nuda, Lentinus edodes, Lactarius sanguifluus, Lentinus squarrosulus, Lactarius deliciosus, Lentius sajor-caju,  
Leucopaxillus giganteus, Lactarius piperatus, Laetiporus sulphureus, Lycoperdon molle, Lycoperdon perlatum, Lactarius piperatus 
[73,74,81,84,91,95,97,99,103,104,106,115,
120,122,125,126,128,133,140,144,145,147] 
Morchella esculenta, Morchella conica, Macrolepiota procera, Morchella angusticeps, Macrolepiota procera [85,91,118,140] 
Pleurotus ostreatus, Pleurotus eryngii, Pleurotus citrinopileatus, Pleurotus djamor, Pleurotus sajor-caju, Pleurotus cystidiosus,  
Pleurotus australis, Pleurotus tuber-regium, Phellinus linteus, Phellinus rimosus, Phellinus merrillii, Polyporus squamosus,  
Picoa juniperi, Pleurotus florida, Pleurotus pulmonarius, Paecilomyces japonica, Piptoporus betulinus 
[50,75,81,88,91–93,95,97,102–104,108, 
115,116,124,133,141,142,144,148] 
Russula brevipes, Russula cyanoxantha, Russula delica, Ramaria botrytis, Russula vinosa [91,101,104,123,140] 
Sparassis crispa, Suillus bellini, Suillus luteus, Suillus granulatus, Sarcodon imbricatus, Schizophyllum commune  [72,91,123,125,140,147] 
Tricholoma acerbum, Tricholoma equestre, Tricholoma giganteum, Tricholomopsis rutilans, Termitomyces microcarpus,  
Termitomyces schimperi, Termitomyces mummiformis, Termitomyces tylerance, Termitomyces heimii, Termitomyces albuminosus, 
Termitomyces robustus, Terfezia claveryi, Tremella fuciformis, Trametes (Coriolus) versicolor, Trametes orientalis 
[74,90,91,93,99,100,114,115,118,123,133,
140,145,147] 
Verpa conica, Volvariella volvacea [103,104,106,120] 
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The various methods used in order to measure the antioxidative properties of mushroom compounds or 
extracts are appropriate for various levels of antioxidative activity, such as methods based on the transfer 
of electrons and hydrogen atoms, the ability to chelate ferrous (Fe2+) and cupric (Cu2+) ions, the electron 
spin resonance (ESR) method, erythrocyte hemolysis, and the monitoring of the activity of SOD, CAT 
and GPx [16,17,72–142,145–147]. 
It has been established that mushroom antioxidants can demonstrate their protective properties at 
different stages of the oxidation process and by different mechanisms [4,6,7]. There are two main types 
of mushroom antioxidants, namely, primary (chain breaking, free radical scavengers) and secondary or 
preventive [4,6,7,16,72–142,145–147]. Secondary antioxidants are the consequence of deactivation of 
metals, inhibition or breakdown of lipid hydroperoxides, regeneration of primary antioxidants, singlet 
oxygen (1O2) quenching, etc. Some mushroom substances that exhibit antioxidant activity function as 
inducers and/or cell signals, leading to changes in gene expression, which result in the activation of 
enzymes that eliminate ROS [6,108–111,149]. 
Different analytical methods have been applied for its identification and quantification: high performance 
liquid chromatography (HPLC) and gas chromatography (GC) coupled to distinct detection devices, 
nuclear magnetic resonance (NMR), Fourier transform infrared (FT-IR), UV-VIS spectroscopy and 
various spectrophotometric assays [16,17,72–148]. 
3.1. Polyphenols Including Flavonoids 
Polyphenols are the most abundant antioxidants in the diet [150]. Research on the effects of dietary 
polyphenols on human health has developed considerably in the past 20 years. One of the major difficulties 
of elucidating the health effects of polyphenols is the large number of phenolic compounds found in 
food [150,151], yielding differing biological activities [152]. 
These compounds may be classified into different groups as a function of the number of phenol rings 
and the structural elements which bind these rings to each other. Thus a distinction is made between the 
phenolic acids, flavonoids, stilbenes, and lignans. In addition to this diversity, most polyphenols are present 
in food in the form of esters, glycosides, or polymers. These substances cannot be absorbed in their native 
form and must be hydrolyzed by intestinal enzymes or by the colonic microflora before absorption. In the 
course of absorption, polyphenols are conjugated and this process mainly includes methylation, sulfation, 
and glucuronidation. Circulating polyphenols are conjugated derivatives that are extensively bound to 
albumin [153]. Nonconjugated metabolites are generally either absent from the blood or present in low 
concentrations [152]. Major differences in bioavailability of polyphenols are now well established facts 
and the influence of structural factors is better understood [152–154]. 
The main phenolic compounds found in mushrooms are phenolic acids [6]. Phenolic acids can be 
divided into two major groups, hydroxybenzoic acids and hydroxycinnamic acids, which are derived from 
the non-phenolic molecules benzoic and cinnamic acid, respectively [6,153,154]. 
Hydroxybenzoic acid derivatives commonly occur in the bound form and are typically a component 
of a complex structure like lignins and hydrolyzable tannins. They can also be found linked to sugars or 
organic acids. Hydroxycinnamic acid derivatives are mainly present in the bound form, linked to cell-wall 
structural components, such as cellulose, lignin, and proteins, as well as associated to organic acids, such 
as tartaric or quinic acids (i.e., chlorogenic acids), through ester bonds [6,153]. 
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The hydroxycinnamic acids are more common than the hydroxybenzoic acids and consist chiefly of 
p-coumaric, caffeic, ferulic, and sinapic acids. These acids are rarely found in the free form, except in 
processed food that has undergone freezing, sterilization, or fermentation. The bound forms are glycosylated 
derivatives or esters of quinic acid, shikimic acid, and tartaric acid [153,154]. 
The most common (prevalent) benzoic acid derivatives found in mushrooms are reported to be  
p-hydroxybenzoic, protocatechuic, gallic, gentisic, homogentisic, vanillic, 5-sulphosalicylic, syringic, 
veratric, vanillin [6]. The majority of identified cinnamic acid derivatives in mushrooms are: p-coumaric, 
o-coumaric, caffeic, ferulic, sinapic, 3-o-caffeoylquinic, 4-o-caffeoylquinic, 5-o-caffeoylquinic [6]. Besides, 
presence of ellagic and tannic acids is observed [6]. 
Natural polyphenolic compounds exert their antioxidant effect by quenching free radical species 
and/or promoting endogenous antioxidant capacity. Furthermore, some of them stimulate synthesis of 
endogenous antioxidant molecules in cells via activating the Nrf/ARE pathway [149,150]. Cells respond 
to polyphenols mainly through direct interactions with receptors or enzymes involved in signal 
transduction, which may result in modification of the redox status of the cell and may trigger a series of 
redox-dependent reactions [150,155–157]. 
Apart from the antioxidant capacity, most of these compounds appear to have a number of different 
molecular targets, impinging on several signaling pathways, and showing pleiotropic activity on cells.  
For instance, polyphenolics can modulate activity of NF-κB or Sirutin1 (SIRT1) exerting neuroprotective 
effects [154,158]. SIRT1 acts as a “rescue gene”, capable to repair damages caused by the action of free 
radicals and to prevent premature death of cells. The gene also affects the mitochondria to produce greater 
amounts of energy what is typical for the metabolism of younger cells. As a result, SIRT1 is believed to 
be a principal regulator of lifespan [158,159]. 
Besides antioxidant properties, polyphenols possess pro-oxidative capacity based upon the structure 
of the particular polyphenol and the cellular redox context that may include increased levels of oxidant 
scavenging proteins or decreased levels of oxidized proteins and lipids [159]. For example, epigallocatechin-
3-gallate (EGCG) induces the activation of protein caspases-3 and c-Jun N-terminal kinases (JNKs), 
which belong to the group of MAPKs that have a role in the process of programmed cell death, i.e., 
apoptosis. These various effects are dependent on cell type, stress conditions, concentrations and the 
time of exposure of EGCG. It is possible that low concentrations of EGCG activate MAPK, leading to 
antioxidant responsive element (ARE)-mediated gene expression, whereas higher concentrations and 
sustained activation of MAPKs lead to apoptosis [7,160]. 
Polyphenols such as tannic acid, gallic acid, and catechin compounds are also known to interact with 
steroid receptors. This may lead to a change of the mitochondrial transmembrane potential and ultimately 
to a decrease or increase in ROS activation, depending on cell systems [142]. As antioxidants, polyphenols 
may improve cell survival; as prooxidants, they may induce apoptosis and prevent tumor growth, and 
combat against bacterial and viral infections by direct oxidative damage or by a variety of innate and 
adaptive mechanisms [150,161]. 
Recently, Lagunes and Trigos [162] showed that polyphenols, e.g., curcumin, resveratrol and quercetin, 
have pro-oxidant activity; they act as photosensitizers in the generation of 1O2. Resveratrol and curcumin 
have been reported as efficient quenchers of 1O2 [163,164]. On the other hand, they have also been reported 
as molecules capable of absorbing ultraviolet-visible (UV-Vis) light and able to transfer it to O2 to generate 
1O2 [162,165]. Recent studies have shown that curcumin is able to inhibit melanoma cells proliferation, 
Molecules 2015, 20 19501 
 
 
under UVA-Vis light, suggesting that it could be used as an adjunctive therapy in the treatment of cancerous 
diseases [166]. Resveratrol and curcumin are lipophilic molecules and mix very well between membrane 
lipids and lipoproteins; their levels in tissues may be higher than those detected in blood [167]. High 
consumption of dietary supplementation with resveratrol and curcumin could lead to a high bioavailability 
in tissues and when these are exposed to light, it would allow resveratrol and curcumin to act as 
photosensitizers, showing a pro-oxidant activity by generation of 1O2. 1O2 is a powerful oxidizing agent 
initiator of oxidation processes in biological systems [168], by which resveratrol and curcumin would favour 
a pro-oxidant effect against normal cells [162]. Analogous processes are likely to occur with lipophilic 
polyphenols of mushrooms, which requires attention should be given to possible harmful effects. 
Flavonoids 
Flavonoid research has intensified since the discovery of the “French paradox” [169,170]. This 
phenomenon was observed in the French population as a significantly lower rate of heart diseases despite 
high consumption of saturated fat and smoking habits and was related to moderate and regular consumption 
of red wine rich in flavonoid compounds [170]. 
Basic structure of flavonoid has a flavan nucleus consisting of two benzene rings (A and B) combined 
by an oxygen-containing pyran ring (C). The various classes of flavonoids differ in their level of oxidation 
of the C ring of the basic 4-oxoflavonoid (2-phenyl-benzo-γ-pyrone) nucleus. The common six subclasses of 
flavonoids are flavonols, flavones, isoflavones, flavanones, anthocyanidins, and flavanols [153,169,171]. 
Flavonoids are most frequently found in nature in the form of glycosylate or esterificate conjugates but 
can also occur as aglycones in food, especially as a result of the food processing. Flavonols are the most 
abundant flavonoids in foods [170,171]. 
In general, it can be assumed that only plants possess the biosynthetic ability to produce flavonoids, while 
animals and fungi are not capable of it [6]. However, the presence of flavonoids is reported in different edible 
mushrooms, e.g., myricetin, chrysin, catechin, hesperetin, naringenin, naringin, formometin, biochanin, 
pyrogallol, resveratrol, quercetin, rutin, kaempferol [6]. More recently, the analysis of the methanolic 
extract of Cantharellus cibarius showed that phenols were its major antioxidant components but followed 
by flavonoids, whose content was approximately 86% of the total phenol content [16]. 
Mechanisms of the antioxidant action of flavonoids can include direct scavenging of RS, chelating of 
trace metal ions involved in RS formation, inhibition of enzymes, e.g., XO and lipoxygenases (LOXs), 
involved in RS production, and regeneration of membrane-bound antioxidants such as α tocopherol [169]. It 
is generally considered that the primary mechanism of the radical scavenging activity of flavonoids is 
hydrogen atom donation. [170,171]. 
The capacity of flavonoids to inhibit ROS is governed by the presence and position of the multiple 
hydroxyl groups in their structure. A double bond and carbonyl function in the heterocycle or polymerization 
of the nuclear structure increases activity by affording a more stable flavonoid radical through conjugation 
and electron delocalization [170,171]. Mechanisms of flavonoid action, such as modulation of signalling 
pathways and gene expression, could also contribute to protective properties of flavonoids [153]. 
Further, flavonoids may act as pro-oxidants based upon on a different number of OH groups in the B 
ring and presence of transient metal ions [170]. The flavonoid phenoxyl radical could interact with O2, 
generating quinones and superoxide anion (O2−), rather than terminating the chain reaction. This reaction 
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may take place in the presence of high levels of transient metal ions and may be responsible for the 
undesired prooxidant effect of flavonoids [170]. 
El Amrani et al. [172] reported oxidative DNA cleavage induced by binding of a Fe3+-flavonoid complex 
to DNA. Likewise, reacting with Cu2+ quercetin induces extensive DNA damage, but kaempferol and luteolin 
induce only slight DNA damage, even in the presence of Cu2+ [170]. These complexes may play an important 
role in their potency for biological action such as angiogenesis and immune-endothelial cell adhesion, 
which, respectively, are important processes in the development of cancer and atherosclerosis [173]. 
Also, it has been shown that quercetin could aggravate the severity of renal cell carcinoma through the 
tumorigenic action mechanism due to pro-oxidant effect [174]. It act as an antioxidant in low doses, or as 
pro-oxidant at higher doses [175].Concerning the absorption and bioavailability of quercetin, it has been 
demonstrated that in an aglycosylated form it becomes a lipophilic molecule and can be easily absorbed 
through epithelia in cells of the colon [162,176]. In a similar manner to resveratrol, quercetin would be 
able to be incorporated into cellular membranes, and under specific conditions, show a pro-oxidant activity 
by generation of 1O2 [162]. 
3.2. Polysaccharides 
Polysaccharides, including polysaccharide-protein complexes, have been recognized as a class of major 
bioactive constituents of edible and medicinal mushrooms [70,71]. They act primarily as adaptogens  
and immunostimulators. The immunostimulatory effect of mushroom polysaccharides is prophylactic 
primarily and it belongs to non-invasive treatments, playing a role in the prevention of infectious diseases 
and of tumor metastases [7,70,71,177,178]. 
Another widely reported activity of mushroom polysaccharides is antioxidative [7,72–77,99,145]. 
Many mushroom polysaccharides have been reported to have significant antioxidant activities based on 
various in vitro and in vivo assays [7,179]. Their antioxidative activity is attributed to the ability of RS 
scavenging, their reduction property and ability to chelate Fe2+, lipid peroxidation inhibition, erythrocyte 
hemolysis and the increase of enzymes activities in eukaryotic as well as in prokaryotic cells as well as 
in taking part in antioxidative processes, such as SOD, CAT and GPx [7,108–111]. 
The extraction procedure and the method used for the purification of the obtained fractions of 
polysaccharides depend in many aspects on the type of a mushrooms and physical properties of 
polysaccharides. Usually these polysaccharides were isolated from the hot-water extract simply by ethanol 
precipitation without further purification [7,72–77,99]. Purification of the crude polysaccharides is usually 
accomplished by chromatographic methods such as size-exclusion (SEC) and ion-exchange chromatography 
(IEC) [99,178], as well as by enzymatic purification using cellulases, amylases and proteases [7,77]. Besides, 
new extraction procedures were reported, as ultrasonic-assisted extraction [145,180] and more recently, 
extraction procedure with a freeze-thawing process [181]. Klaus et al. [76] have managed to encapsulate 
polysaccharide extracts from G. frondosa in alginate gel beads to protect them from external influences 
and this could contribute to a more widespread use. 
Some studies have found that the purified mushroom polysaccharides had lower antioxidant activities 
than the original crude extracts [99,146]. Polysaccharides in the fungal cell wall may be bound by 
covalent (ester) linkages with proteins via remains of tyrosine and/or with ferulic acid as a result of lignin 
degradation processes [7,74]. However, other studies reported higher antioxidant activity in the pure 
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polysaccharide fraction, e.g., the A. brasiliensis polysaccharides obtained by pronase deproteinization, 
demonstrated a high antioxidative activity against •OH and •O2− radicals measured by electron paramagnetic 
resonance (EPR) spin-trapping spectroscopy. These polysaccharides consisted mainly of (1→6)-β-D-
glucans [77]. 
The major antioxidant effects of mushrooms are attributed to β-glycans. Except reported antioxidant 
properties, α-glycans are eukaryotic nutrient components and are easily degraded by mammalian enzymes. 
β-Glycans from various mushrooms can be taken up by the M cells of Peyer’s patches, and/or interact 
with dendritic cells (DCs) in the small intestine to activate systemic organism responses [182,183]. 
The ability of the polysaccharide molecules to scavenge free radicals may be conditioned by the 
presence of hydrogen from specific, certain monosaccharide units, and the type of their binding in side 
branches of the main chain [84,184]. The enhanced antioxidant activity of the polymers over the 
monomeric form may be due to the greater ease of abstraction of the anomeric hydrogen from one of the 
internal monosaccharide units rather than from the reducing end [184]. 
Recently, Kishk and Al-Sayed [185] reported that the •OH scavenging mechanism of polysaccharides 
was perhaps similar to that of phenol compounds by hydrogen atom transfer (HAT) reactions. However, 
the HAT reaction is more likely to occur in the neutral polysaccharides, while the electron transfer (ET) 
mechanism is usually occur in the acidic polysaccharides. 
Mushroom polysaccharides and glycoconjugates may be useful in creating new natural-based 
medications or dietary supplements and helpful in the prevention and treatment of oxidative stress-mediated 
disorders. ROS are produced within the GI tract. Despite the protective barrier provided by the mucosa, 
ingested materials and microbial pathogens can induce oxidative injury and GI inflammatory responses 
involving the epithelium and immune/inflammatory cells. High antioxidative capacities of polysaccharides 
from edible mushrooms can prevent lipid peroxidation [72–77] and the pathogenesis of various GI diseases 
including peptic ulcers [186], GI cancers [182], and inflammatory bowel disease which is in part due to 
oxidative stress [25]. 
Cytotoxic effects of polysaccharide extracts of higher fungi on normal cells have not been reported 
up-to-date [7,73,77]. Furthermore, it was confirmed that polysaccharide extract of G. lucidum, in vitro, 
stimulates proliferation of HTR-8/SVneo trophoblast cells which are essential for normal placentation, 
establishment of pregnancy and maintenance of fetal growth in humans [73,187]. 
The polysaccharide extracts proved to be heat stable and retained high antioxidant potential, despite 
all the treatments applied in their preparation [72–77]. 
3.3. Vitamins 
3.3.1. Vitamin C 
Vitamin C, also known as L-ascorbic acid, is the primary antioxidant in plasma and cells [25]. It is an 
essential nutrient for a limited species of animals, including humans, and therefore must be ingested to 
avoid a potentially lethal condition [6,25,188]. Likewise, ascorbic acid is a normal skin constituent found 
at high levels in both the dermis and epidermis [189,190]. Ageing, however, causes a decline in vitamin C 
content in both layers. Excessive exposures to UV light or pollutants (e.g., cigarette smoke and ozone) may 
also lower its content, primarily in the epidermis [189,190]. 
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Vitamin C was detected in various edible mushrooms [6,16]. It was quantified by HPLC or 
spectrophotometric assay, based on the reaction with 2,6-dichlorophenolindophenol [6,16]. Kozarski  
et al. [16], found 100 mg/100 g dry weight (DW) of ascorbic acid in the methanolic extract of the wild 
edible mushroom Cantharellus cibarius. It was higher than its content in some fruits and vegetables which 
are usually recommended as a good source of vitamin C [191]. Reported amount of ascorbic acid found in 
strawberries is 60 mg/100 g, citrus fruits 30–50 mg/100 g, while apples, pears and plums represent only a 
very modest source of ascorbic acid (3–5 mg/100 g) [191]. 
Grangeia et al. [192] found high concentrations of ascorbic acid in the methanolic extracts of different 
saprotrophic and mycorrhizal wild edible mushrooms (81.32–400.36 mg/100 g DW). 
Ascorbic acid has been shown as an effective RS scavenger [188,191]. In studies with human plasma 
lipids it appeared that ascorbate was far more effective in inhibiting lipid peroxidation initiated by a lipid 
peroxyl radical (•LOO) initiator than other plasma components, such as protein thiols, urate, bilirubin, and 
vitamin E. In the aqueous phase, ascorbic acid can protect biomembranes against peroxidative damage 
by the efficiently trapping •LOO before they can initiate lipid peroxidation [188,191]. It may also  
recycle vitamin E, the main lipid-soluble antioxidant. Ascorbic acid reacts rapidly with the tocopherol 
radical by reducing the ascorbate radical (semidehydroascorbate) to ascorbate by NADH-dependent 
semidehydroascorbate reductase [6,25]: 
Ascorbic acid + •Tocopherol → Ascorbate + Tocopherol  
Ascorbate + NADH → Ascorbate + •NAD (1)
Although the main function of ascorbic acid is antioxidant, under certain circumstances, it can also have 
a pro-oxidant effect, in particular by maintaining the transition metal ions, Fe3+ and Cu2+ in their reduced 
forms. These metal ions react then with H2O2 to form the highly reactive ·OH in the Fenton reaction [25,191]. 
But there is currently no clear evidence that these reactions are of significance in vivo [25,191]: 
Fe3+ + Ascorbic acid → Fe2+ + •Ascorbate  
Fe2+ + H2O2 → •OH + OH− + Fe3+ (2)
3.3.2. Vitamin E 
The term “vitamin E” does not refer to a single molecule but rather is frequently used to designate a 
family of chemically related compounds, namely tocopherols and tocotrienols, which share a common 
structure with a chromanol ring and isoprenic side chain [188]. α, β, γ, and δ Tocopherols were identified 
and quantified in edible mushrooms. However till now, tocotrienols were not detected in any of the 
available studies [6]. 
Biologically the most active form of vitamin E is α tocopherol whose main role is to protect cell 
membranes from lipid peroxidation (LPO) [25,188]. α Tocopherol terminates the activity of LPO by 
scavenging ·LOO, but during this reaction is itself converted into a reactive radical [6,25]: 
LH + Oxidant initiator → •L  
•L + O2 → •LOO  
•LOO + Tocopherol → LOOH + •Tocopherol 
(3)
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α-Tocopherol can also act as a prooxidant and reduces Fe3+ or Cu2+ [193]. The ability of α tocopherol to 
act as a pro- or antioxidant depends mainly on its amount which is available for scavenging of ROS [193]. 
Epidemiological studies indicate that diets rich in fruits and vegetables lower GI cancer rates, but 
supplementation of exogenous vitamin E and other antioxidants (β-carotene, vitamins A, C and Se) have not 
been shown to prevent GI cancers [194]. In some cases, vitamin E increases cancer risks [195]. Likewise, 
supplementing vitamin E has been shown to significantly increase lung cancer progression and reduce 
survival rate in mouse models [196]. As the expression of endogenous antioxidant genes is reduced by the 
introduction of antioxidant supplements, the tumor transcriptome profile is altered with a downregulation 
of p53 (tumor suppressor protein gene) expression level accordingly [197]. These changes provide an 
explanation on why antioxidants may promote cancer development [195]. 
The amounts of tocopherols detected in edible mushrooms were much lower that those measured in some 
groceries which are usually recommended as a good source of vitamin E [6,139,147,192]. Compared with 
foods high in vitamin E content, e.g., almonds (26.2 mg/100 g), roasted sunflower seeds (36.3 mg/100 g), 
avocados (2.1 mg/100 g), tofu (5.3 mg/100 g), shrimp (2.2 mg/100 g) etc., the tocopherols content in edible 
mushrooms is measured to be between 0.02 and 200 μg/100 g DW [139,147,192,198]. 
3.3.3. Vitamin A Including Carotenoids 
Carotenoids are natural pigments. There are several dozen carotenoids in foods. The predominant 
carotenoids in the diet and human body are represented by β-carotene, α-carotene, lycopene, lutein and 
β-cryptoxanthin, of which β-carotene, α-carotene, and β-cryptoxanthin are able to function as provitamin 
A and play important roles as vitamin A dietary sources [199]. Recent interest in carotenoids has focused 
on the role of lycopene in human health. It does not have pro-vitamin A properties. Because of the 
unsaturated nature of lycopene it is considered to be a potent antioxidant and a 1O2 quencher. Lycopene 
was shown to cross the blood brain barrier and be present in the central nervous system in low 
concentrations. Significant reduction in the levels of lycopene was reported in Parkinson’s disease and 
vascular dementia patients [199,200]. 
Particularly, β-carotene and lutein were found in several mushroom species [6,16,201]. Carotenoids 
found in the pink-red Cantharellus cinnabarinus and the orange Cantharellus friesii are composed almost 
entirely of canthaxanthin, a pigment also found in the salmon [201]. It might explain the use of chanterelles 
by Chinese herbalists in treating night blindness [201]. Canthaxanthin is reported to protect human 
tissues from oxidative damage and is sold as an antioxidant [201]. 
Carotenoids can react with ROS and become radicals themselves. They function as a chain-breaking 
antioxidant in a lipid environment, especially under low oxygen partial pressure. The extensive systems 
of double bonds make carotenoids susceptible to attack •LOO, resulting in the formation of inactive 
products [202,203]. 
Carotenoids reactivity depends on the length of conjugated double bonds chain and the characteristics 
of the end groups [202]. Carotenoid radicals are stable by virtue of the delocalization of the unpaired 
electron over the conjugated polyene chain of the molecules. This delocalization also allows additional 
reactions which occur at many sites on the radical. The carotenoid radicals are very short-lived species [202]. 
The antioxidant properties of carotenoids can be reversed to pro-oxidant behavior depending on oxygen 
pressure or carotenoid concentration [14,25,203]. It is established that β-carotene loses its antioxidant 
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activity when the normal ambient oxygen pressure increases, and has an autocatalytic pro-oxidant effect 
which increases with its concentration [7,203]. Studies of food supplementation with large doses of  
β-carotene in smokers have shown an increase in cancer risk, possibly because β-carotene under intense 
oxidative stress (e.g., induced by heavy smoking) gives breakdown products that reduce plasma vitamin 
A and worsen the lung cell proliferation induced by smoke [149,203]. Frequent use of vitamin C and 
vitamin E in the period after breast cancer diagnosis was associated with a decreased likelihood of recurrence, 
whereas frequent use of combination carotenoids was associated with increased mortality [204]. 
3.3.4. Vitamin D 
Vitamin D refers to a group of fat-soluble secosteroids responsible for enhancing intestinal absorption 
of calcium (Ca), Fe, magnesium (Mg), P and Zn [205–207]. The importance of vitamin D in bone (Ca2+ 
ion homeostasis) is well established, and vitamin D has been the subject of increased attention in recent 
years for its role in muscle function, immunology, heart and cardiovascular disease, cancer, and insulin 
secretion [208]. 
In humans, the most important compounds in this group are vitamin D3, also known as cholecalciferol 
and vitamin D2, or ergocalciferol. Both cholecalciferol and ergocalciferol are inactive themselves, but are 
metabolized in the liver to 25-hydroxyvitamin D and further in the kidney to the biologically active form, 
1,2,5-dihydroxyvitamin D. The serum concentration of 25-hydroxyvitamin D is considered to be a good 
indicator of vitamin D status in humans [209]. 
Vitamin D3 originates from animal sources, and vitamin D2 is derived predominantly from mushrooms 
and yeast [208]. Vitamin D2 contents in mushrooms, cultivated or harvested wild, is available but varies 
significantly with and within different species and by developmental stage [210,211]. Differences of 
climate, habitat, and degree of latitude may cause variation in ergocalciferol contents of mushrooms [210]. 
For example, content of only 0–3.75 μg/100 g of fresh weight has been found in A. bisporus [210,212–214] 
and 0.04 [215] to 21.8–109.6 μg/100 g DW [216] in L. edodes. 
The vitamin D2 content of mushrooms can be increased dramatically by UV irradiation, whereby it is 
formed from ergosterol that is present in large amounts [208,217–220]. Outila et al. [209] showed for 
the first time that ergocalciferol was well absorbed in humans from lyophilized and homogenized wild 
edible mushrooms. 
Vitamin D3 and D2, its active metabolite 1,25-dihydroxycholecalciferol and also 7-dehydrocholesterol 
(pro-Vitamin D3) are a membrane antioxidants and inhibit iron-dependent liposomal lipid peroxidation [207]. 
The structural basis for the antioxidant ability of these vitamin D compounds is considered in terms of 
their molecular relationship to cholesterol and ergosterol [207]. 
Biologically active, 1,25-dihydroxyvitamin D, binds to the vitamin D receptor on cells and plays a role 
not only in Ca2+ uptake but also in differentiation [50,208,211]. Furthermore, by decreasing membrane 
fluidity by the membrane interaction that is thought to lead to the observed inhibition of iron-dependent 
liposomal lipid peroxidation [207], Vitamin D could help inhibit the growth of cancer cells (especially 
metastatic cells), which often have increased membrane fluidity compared to normal cells [221]. 
Van Griensven and Verhoeven reported [50] that crude polysaccharides extract of Phellinus linteus 
increased the mitochondrial membrane potential (MMP) and causes apoptotic death of THP-1 monocytes. 
They concluded that there are two major factors determining differentiation and/or death of polysaccharide 
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extract treated THP-1 cells, i.e., a death receptor (TRAIL-like) binding activity on the one hand, and 
oxidative stress and Ca2+ homeostasis on the other. It was confirmed that P. linteus polysaccharides extract 
increased mitochondrial Ca2+ concentration, resulting in breakdown of the outer mitochondrial membrane 
and induction of apoptosis [222]. Apoptosis through the mitochondrial pathway merely seems to be caused 
by disturbance of the mitochondrial Ca2+ homeostasis [223]. Changes in the MMP and Ca2+ homeostasis 
play a prominent role in the pathogenesis of age related loss of neuronal function, such as that occurring 
in Alzheimer’s disease [224] and Parkinson's disease [225]. Hyperpolarizing compounds e.g., vitamine D2, 
in P. linteus might restore Ca2+ homeostasis and thereby prevent the loss of neuronal function [50]. 
3.3.5. Ergothioneine 
Ergothioneine (ET) is an unusual sulfur-containing derivative of the amino acid, histidine, which is 
obtained exclusively through the diet. Recently, a highly specific transporter for ET (ETT) was identified 
(integral membrane protein, OCTN1) in mammalian tissues, which explains abundant tissue levels of ET 
and implies its physiological role [226,227]. Cells lacking ETT are more susceptible to oxidative stress, 
resulting in increased mitochondrial DNA damage, protein oxidation and lipid peroxidation. ET is 
concentrated in mitochondria, suggesting a specific role in protecting mitochondrial components, such 
as DNA, from oxidative damage associated with mitochondrial generation of •O2−. Because of its dietary 
origin and the toxicity associated with its depletion, ET may represent a new vitamin whose physiological 
roles include antioxidant protection [226,227]. 
Mushrooms are a primary source of ET containing from 400 to 2500 mg/g DW [17,143].  
Weigand-Heller et al. [135] reported that ET from A. bisporus is bioavailable as assessed by red blood 
cell uptake postprandially. Consumption is associated with an attenuated postprandial triglyceride  
(TG) response. 
By analyzing the fruiting bodies and mycelia of 29 edible and medicinal mushrooms species  
Chen et al. [17] confirmed presence of ET in all samples. The highest amount was observed among 
fruiting bodies of edible species, P. citrinopileatus, P. ostreatus (Korea), P. ostreatus (Taiwan) and  
P. salmoneostramineus (2850.7, 1829.4, 1458.4 and 1245.0 mg/kg, respectively) whereas among mycelia, 
P. eryngii contained the highest amount (1514.6 mg/kg). Dubost et al. [143] also found the ET content 
of P. ostreatus to be the highest (2590 mg/kg DW). It seems that mushrooms are an abundant source of 
ET [17,136–138,143]. 
3.4. Minerals 
Mushrooms are generally capable of accumulating trace elements and then become their source in 
the food chain [228,229]. Trace elements Zn, Cu, Mn and Fe are cofactors of enzymes with antioxidant 
functions and are designated as antioxidant micronutrients [25]. Se is a major antioxidant in the form  
of selenoproteins that reduce the cytotoxic effects of ROS. GPx and selenoprotein-P are dominant Se 
compounds secreted in the blood [229]. In mushrooms, several Se compounds have been identified including 
selenomethionine, selenocysteine, Se-methylselenocysteine, selenite and seleno-polysaccharides [230–232]. 
Factors influencing the bioaccumulation of trace elements in mushrooms and the biological importance 
of the accumulation process itself are poorly understood. However, the following fundamentals have been 
recognized: natural factors (bedrock geochemistry), metalliferous areas and environmental pollution, 
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fungal environment, bioaccumulation of trace elements in fruit bodies is highly specific: some macrofungi 
are able to accumulate elements much more effectively than others, the accumulation process can be highly 
element specific- macrofungi may even discriminate elements with similar properties and chemical 
behavior (homologues) [229,233]. Moreover, wild-grown edible mushrooms can accumulate minerals 
essential to humans in a much greater extent than cultivated edible mushroom [229]. 
However, it should also be kept in mind that these essential metals can also produce toxic effects when 
their intake is excessively elevated [228,229]. For example, in vitro and in vivo experiments have indicated 
that Se prevents carcinogenesis, but a high concentration of Se can be cytotoxic [234]. Se conjugates with 
two GSH to form the metabolite selenodiglutathione (GSSeSG), a potent compound that enhances ROS 
production, DNA damage and apoptosis [235]. Besides exogenous antioxidant treatments, the modulation 
of the endogenous antioxidant system can also be cytotoxic. Over expressed glutamate cysteine ligase 
(GCL), GCL catalytic subunit (GCLC) or GCL modifier subunit (GCLM) can lead to an imbalanced 
GSH/GSSG ratio. Excess GSH shifts the cells to reductive stress, which can cause mitochondrial oxidation 
and cytotoxicity [195,236]. 
Many edible mushroom species are known to accumulate high levels of heavy metals, mainly 
cadmium (Cd) and lead (Pb) [237–240]. Divalent metal cations belonging to the transition elements may 
pass into the mitochondria through membrane channels for essential group elements [241]. For example Pb2+ 
ions seem to be transported into human and animal mitochondria through the Ca2+ transporters [241,242]. 
Also, after reaching the cytoplasm, Pb2+ continues its destructive mimicking action by occupying the 
Ca2+ binding sites on numerous Ca-dependent proteins. Pb2+ has high affinity for Ca-binding sites in the 
proteins; a pM concentration of Pb2+ can replace Ca2+ in μM concentrations [242]. 
Cd2+ ions can replace Fe2+ and Cu2+ from a number of cytoplasmic and membrane proteins like ferritin, 
thereby causing rise in the concentration of Fe2+ and Cu2+ ions which may be associated with the production 
of oxidative stress via the Fenton reaction [243]. Another mechanism of Cd2+ toxicity may be carried out 
in the body by Zn2+ binding proteins. Cd2+ can bind up to ten times more strongly than Zn2+ in certain 
biological systems and is notoriously difficult to remove [242]. 
Another target for Pb2+ and Cd2+ attack could be a thiol group (-SH) containing enzymes involved in 
antioxidant mechanisms, i.e., Cd2+ forms Cd-Se complexes in the active centre of GPx and inhibits the 
enzyme activity [242]. Likewise, Cd2+ and Pb2+ inhibit complex III of the mitochondrial electronic 
transport chain, divert the electron flow and increase production of ROS [244] which may damage the 
mitochondrial membrane and trigger onset of apoptosis. In addition, changes in mitochondrial oxidative 
metabolism may lead to energy deficit thereby affecting the essential cellular functions. Thus, Cd and 
Pb are capable of eliciting of ROS, which could be the main mechanism of cellular toxicity induced by 
these heavy metals [241,242,245]. 
4. Conclusions 
Oxidative stress plays a significant role in ageing processes and increases the risk of chronic diseases. The 
ability to resist or prevent oxidative stress is a key determinant of longevity. Enhancement of antioxidant 
defenses through dietary supplementation would seem to provide a reasonable approach to reduce the 
level of oxidative stress. There is a wealth of evidence to support the effectiveness of such a strategy  
in vitro [14]. 
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Edible mushrooms have been related to significant antioxidant properties due to their bioactive 
compounds, such as polyphenols, polysaccharides, vitamins, carotenoids and minerals. Wild or cultivated, 
they are a primary source of ergothioneine which has specific role in protecting mitochondrial components 
from oxidative damage associated with generation of ·O2− via the escape of electrons from the mitochondrial 
ETS. Likewise they are becoming increasingly important in our nutrition due to their high amounts of 
valuable proteins and low total fat levels, making them well suited for the prevention and treatment of 
obesity. Mushrooms are also very appreciated for their texture, flavor, and versatility in culinary activities. 
They can be easily incorporated into any kind of dish, improving the dietary diversity without adding 
many calories. Antioxidant and health benefits, observed in edible mushrooms, seem an additional reason 
for their use as a popular delicacy food. Besides, mushroom antioxidants are particularly of interest to the 
present generation because they have the potential to substantially reduce the expensive, high-tech, disease 
treatment approaches presently being employed in healthcare [2,148]. 
Nonetheless, successful implementation of mushroom antioxidants still remains insufficiently explored. 
To act in vivo, antioxidants would need to be incorporated into the tissues in the correct location and at a 
suitable concentration relative to the oxidizing agent and the molecule to be protected. In addition, some 
of mushroom ROS scavengers act in oxidation-reduction reactions that are reversible, and some can act 
both as antioxidants and pro-oxidants, depending on the conditions. Besides, the human population is 
heterogeneous regarding ROS levels which in moderate concentrations are necessary for a number of 
protective reactions. Intake of mushroom antioxidants could protect against cancer and other degenerative 
diseases in people with innate or acquired high levels of ROS. Abundant antioxidants might suppress these 
protective functions, particularly in people with a low innate baseline level of ROS [42,56,195,204,246]. 
Likewise, standardization of antioxidant dietary supplements from mushrooms is still in progress [13]. 
There are insufficient data to determine which antioxidant components are more effective and have a 
higher safety profile, purified mushroom extracts and fractions thereof, or the original crude. One of the 
main targets of mushroom antioxidants researches should be to postulate these standards. 
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